T-DXd Versus THP for Medium-risk HER2-positive Early Breast Cancer

Clinical trial NCT06548178 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06548178
Sponsor: Fudan University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-positive Breast Cancer

Start date: 2024-09-01
Primary completion: 2025-09-01
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.